• Titrate to clinically effective sedation
• Maintain respiratory stability
• Continuous patient comfort

Precedex is a relatively selective alpha2-agonist approved for the sedation in initially intubated and mechanically ventilated patients in the intensive care setting. It is administered by continuous infusion not to exceed 24 hours. Precedex can be used before, during and after extubation.

• Precedex is indicated for sedation of initially intubated and mechanically ventilated patients during treatment in an intensive care setting.
• Precedex should be administered by continuous infusion not to exceed 24 hours.
• Caution should be exercised when administering Precedex to patients with advanced heart block and/or severe ventricular dysfunction.